CN104856799B - Ophtalmic treatments device - Google Patents
Ophtalmic treatments device Download PDFInfo
- Publication number
- CN104856799B CN104856799B CN201510330977.4A CN201510330977A CN104856799B CN 104856799 B CN104856799 B CN 104856799B CN 201510330977 A CN201510330977 A CN 201510330977A CN 104856799 B CN104856799 B CN 104856799B
- Authority
- CN
- China
- Prior art keywords
- housing
- post
- pad
- eyelet
- smoke evacuation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 30
- 239000000779 smoke Substances 0.000 claims abstract description 44
- 239000003995 emulsifying agent Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 10
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 7
- 239000004816 latex Substances 0.000 claims description 7
- 229920000126 latex Polymers 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 6
- 238000009826 distribution Methods 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 239000003517 fume Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000003999 initiator Substances 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 230000002902 bimodal effect Effects 0.000 claims description 3
- 239000004594 Masterbatch (MB) Substances 0.000 claims description 2
- 238000010008 shearing Methods 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 230000004379 myopia Effects 0.000 abstract description 10
- 208000001491 myopia Diseases 0.000 abstract description 10
- 201000009487 Amblyopia Diseases 0.000 abstract description 8
- 238000002560 therapeutic procedure Methods 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000002177 Cataract Diseases 0.000 abstract description 3
- 206010020675 Hypermetropia Diseases 0.000 abstract description 3
- 230000004305 hyperopia Effects 0.000 abstract description 3
- 201000006318 hyperopia Diseases 0.000 abstract description 3
- 201000008525 senile cataract Diseases 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 23
- 230000001225 therapeutic effect Effects 0.000 description 16
- 238000001467 acupuncture Methods 0.000 description 10
- 208000030533 eye disease Diseases 0.000 description 10
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 230000001886 ciliary effect Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229920000049 Carbon (fiber) Polymers 0.000 description 3
- 239000004917 carbon fiber Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 210000004279 orbit Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 241000758789 Juglans Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 229910018879 Pt—Pd Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 206010001912 Amblyopia strabismic Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 201000009406 ametropic amblyopia Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000004329 axial myopia Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- SZGZILRQIYNODJ-UHFFFAOYSA-L disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N=C(C=C3C(NC4=CC=C(C=C4N3)S(=O)(=O)[O-])=C3)C3=NC2=C1 SZGZILRQIYNODJ-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000004344 low myopia Effects 0.000 description 1
- 230000004315 low visual acuity Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000004423 myopia development Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 201000009485 suppression amblyopia Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Disclose a kind of ophtalmic treatments device, including the housing of periscopic, multiple convection holes are offered on the housing, eyelet pad is equiped with the opening of back side of shell, a left side for eyelet pad, right part position is respectively equiped with the porous eyeglass communicated with enclosure interior, it is left, nose pad is provided between right porous eyeglass, the upper end of housing is provided with a left side, right smoke evacuation post, it is left, the top surface of right smoke evacuation post is provided with exhaust smoke hole, it is left, smoke evacuation cap is arranged with right smoke evacuation post, housing lower end is provided with a left side, right ash hole, which is provided with ash groove, it is left, setting up in right ash groove has the moxibustion post fixed station for putting moxibustion post.Alleviation and treatment of the therapy equipment to ophthalmic diseasess such as youngsters and children amblyopia, myopia, hypermetropia, stravismus and senile cataracts have certain effect.
Description
Technical field
The invention belongs to a kind for the treatment of or alleviate the medical device of ocular disease, it is more particularly to a kind of to amblyopia, it is near
There is the ophtalmic treatments device of certain treatment or mitigation depending on ophthalmic diseasess such as, cataract.
Background technology
With myopia, the increase of amblyopia crowd, various eye treatments, health product are also more and more.Myopia mainly by
In excess eye-using, ciliary muscle is chronically at spasticity and causes, and some therapeutic instruments can make ciliary muscle by tempering ciliary muscle
Regulatory function strengthen, have certain help to improving vision.General therapeutic instrument for shortsightedness is all by simulating human eye
Recover ciliary muscle and lenticular tune by closely to remote vision process, the exercise repeatedly for make the rhythmic contraction of ciliary muscle, loosening
Energy-conservation power, prevents and treats myopia.Meanwhile, these therapeutic instruments are also by pressing to meridian point around eyes and nervous tissue
Rub, control and adjust visual performance, improve eye blood supply situation, further strengthen therapeutic effect.But, above treatment principle is simultaneously
Treatment or mitigation can not be played to myopia and amblyopia fundamentally.
Because an important mechanisms of the generation development of myopia are the contracts lasts of ciliary muscle, cause anxiety or spasm, and
Pulled choroid, ocular circulation occurs obstacle, secondary eye histiocyte malnutrition and atrophy, further leads
Cause sclera elasticity to weaken, cause the generation of axial myopia.
So, how a kind of ophtalmic treatments device is provided, the blood circulation of eyeball deep tissue is carried out by therapeutic instrument
Improve, dredging the meridian, to reach the purpose for safely, effectively, easily treating and preventing the low visual acuity oculopathy such as myopia, amblyopia, be
Eye illness control worker explores, an important topic of research.
CN201019908U discloses a kind of eye diseases therapy, including the housing of a spectacle, it is characterized in that：The housing is just
Face is blind end, offers multiple convection holes thereon, is equiped with eyelet pad on the opening of back side of shell, eyelet pad it is left and right
Position is respectively equiped with the porous eyeglass communicated with enclosure interior, and nose pad, the upper end of housing are provided between left and right porous eyeglass
The left and right smoke evacuation post being integrated with housing injection is provided with, the top surface and side wall of left and right smoke evacuation post offer exhaust smoke hole, left and right row
Rotatable smoke evacuation cap is arranged with the column of smoke all, the top surface and side wall of cap of discharging fume are provided with the exhaust smoke hole with smoke evacuation capital face and side wall
Coincide the exhaust smoke hole for opening and closing, and housing lower end is provided with left and right ash hole, and spiral shell is provided with ash groove, left and right ash groove and all sets up thereon
There is the moxibustion post fixed mount for putting moxibustion post.The full content of the utility model is expressly incorporated herein by quoting.
CN1286966A discloses a kind of medical apparatus and instruments for treating oculopathy.Eye disease treating instrument solves Current therapeutic oculopathy
The treatment oculopathy that medical apparatus and instruments are present is single, controls the problem that table does not effect a permanent cure.The appearance medicine box of this therapeutic instrument, agitator, electric pulse are sent out
Raw device be placed in inside and outside plate shape into interlayer in, and mutually fix with interlayer, several massage columns be fixed with inner panel, some
Eyeshield, medicinal liquid diffuser plate, heater are sequentially installed with the centre that individual massage column is formed, between these parts, pass through wire
Or mozzle connects, therapeutic instrument scientific structure is simple, to various oculopathy treating both the principal and secondary aspects of a disease, evident in efficacy.
CN101375815A discloses a kind of eye therapeutic apparatus, more particularly to one kind adjusts the eye dioptrics such as myopia, hypermetropia
Not positive disease therapeutic equipment, it is the glue being connected by the mould suction nozzle and mould suction nozzle that are provided with air duct that front end and eyeball are matched
Pipe, and sebific duct connection negative pressure source constitute.
CN101822872A discloses a kind of eye near-infrared light therapeutic apparatus, it is characterised in that：Including power supply, it is securable to people
Body head simultaneously covers the eyeshield of eye, some near-infrared light sources powered on eyeshield and by power supply, and corresponds to control respectively
Some switches of each near-infrared light source break-make are made, the near-infrared light source irradiation position correspondence eye Chinese medicine acupoint is described near red
The wave band of outer light source at least includes one of 670nm and 830nm.
CN104224435A discloses a kind of therapeutic instrument for treating ophthalmic diseasess, it is characterised in that：It include to
Generation can excite patient to produce visual effect, can be converted into the electric pulse of the photostimulation to human eye depending on the transmission of excited, visual information
Generator, battery lead plate and drug application patch, the electric impulse production device produce dress by wire connection electrode plate, electric pulse
The electric pulse for putting generation is transmitted to drug application by battery lead plate and sticks, and the drug application is sticked containing can treat ophthalmology visual disorder disease
Ingredient medicinal liquid；The electric pulse that the electric impulse production device is produced be two different pulse frequencies be modulated with
The multiple harmonic for generating afterwards, in described two pulses, one is low-frequency pulse, and frequency range is 30～60Hz, and another is intermediate frequency
Pulse, frequency range are 5000～7000Hz, and the multiple harmonic of 30～7000Hz is generated after two impulse modulations.
CN203598214U discloses a kind of eye diseases therapy, including the housing of single injection-molded, and the housing is horizontal stroke
Cuboid of the section for glasses type, it is characterised in that：The housing forward end is blind end and is provided with convection holes, pacifies in the housing
Equipped with the picture frame agreed with hull shape, two panels porous eyeglass is installed on the picture frame, the upper end of housing is provided with movable rows
Cigarette device, is provided with dust collect plant below housing, electro-heat equipment, the activity smoke evacuation are provided with inside the movable smoke extractor
Device and dust collect plant are two, and the housing internal layer is provided with heat-insulation layer.
CN1711980A discloses a kind of vision frequency spectrograph, including light source body, body and eyepatch body, and light source body is installed
In the eyeshield body, the eyepatch body is arranged on the body, it is characterised in that：Also include tumbler, the eyepatch body is by being somebody's turn to do
Tumbler and may be rotatably mounted on body.
CN204016856U discloses a kind of eye socket acupuncture and moxibustion therapeutic apparatus, and it includes acupuncture and moxibustion therapy instrument apparatus, wire, its feature
It is：Eyelet being provided with the eye patch of eyeshield shape, acupuncture pole piece being provided with around eyelet periphery, acupuncture pole piece passes through wire and acupuncture
Treatment instrument apparatus UNICOM.
CN1203067A discloses a kind of multifunctional therapeutic apparatus for ophthalmopathy, and it can by power circuit, frequency of oscillation and dutycycle
The oscillation inverter circuit of tune, fixed frequency oscillating circuit, electronic switching circuit, the liquid crystal glasses eyeglass and plastics eye before right and left eyes
Mirror mirror holder is constituted.
CN203662971U discloses a kind of eye diseases therapy, it is characterised in that：Two eye positions of the eyeshield body
Above be provided with carbon fiber wire heater, behind be provided with nonwoven, through air layer of cloth, the nonwoven, through air layer of cloth is around two eye sockets
Multiple tourmaline particle bags are provided near each acupuncture point, medicine are provided between carbon fiber wire heater and nonwoven, through air layer of cloth
Thing cloth bag, the controller of the carbon fiber wire heater connection with temperature control equipment.
CN202961117U discloses a kind of eye fumigation massage therapeutic equipment, including：Steam gassing machine；Vapour is led by first
The medical ultrasonic atomizer that pipe is connected with steam gassing machine；And the eye being connected with medical ultrasonic atomizer by the second steam guiding tube
Portion's massage device.
" introducing a kind of moxibustion spectacle frame ", Chen Shaohua etc., Chinese TCM Ophthalmology magazine, the 1st phase of volume 12,2 months 2002,
Disclose in glasses inframe with appropriate absorbent cotton pad bottom, be put into walnut shell, instill the another herb liquid prepared a little, moxa roll is inserted respectively
On medicine plug-in unit, gap is reserved between moxa roll and walnut shell, moxa roll is lighted, is put on one's glasses, acupuncture point around eye socket can be carried out
Moxibustion, during treatment, patient opens eyes.
Previously eye diseases therapy disclosed in the CN201019908U granted patent of application had proved to be a kind for the treatment of or slow
The more effective device of the symptoms such as solution amblyopia, hypermetropia, is widely used, but the inventors discovered that, in the apparatus,
The conventional nose pad and eyelet cushion material for using easily becomes sticky in the presence of acupuncture smog, even results in and cannot use and report
Useless, the present invention is had been surprisingly found that based on this, and through numerous studies and test, obtains the present invention.
The content of the invention
The invention aims to solve the above problems, the present inventor proposes one through further investigation and many experiments
Ophtalmic treatments device is planted, the nose pad and eyelet pad of the ophtalmic treatments device are made up of release polymer.
In one aspect of the invention, there is provided a kind of ophtalmic treatments device, which includes the housing of periscopic, the housing
Front is blind end, offers multiple convection holes thereon, is equiped with eyelet pad on the opening of back side of shell, a left side for eyelet pad,
Right part position is respectively equiped with the porous eyeglass communicated with enclosure interior, is provided with nose pad between left and right porous eyeglass, housing it is upper
End is provided with the left and right smoke evacuation post being integrated with housing injection, and the top surface of left and right smoke evacuation post is provided with exhaust smoke hole, on left and right smoke evacuation post
Smoke evacuation cap is arranged with, the top surface of cap of discharging fume is provided with adjustable exhaust smoke hole, and exhaust smoke hole is provided with and can close blade and knob post, shell
The lower end of body is provided with left and right ash hole, and which is provided with has the moxibustion post for putting moxibustion post solid
Determine platform, it is characterised in that：The eyelet pad and nose pad are made up of release polymer.
The composition of the present inventor's further investigation moxibustion tobacco and the reason for cause tacky, it is proposed that the eyelet pad and nose pad by
Release polymer is made.Preferably, the polrvinyl chloride is the polrvinyl chloride produced by microdroplet suspension process.
The microdroplet suspension process is comprised the following steps：（1）Vinyl chloride, water, emulsifying agent and oil-soluble initiator are being divided
In the presence of scattered pump, the Vinyl Chloride Monomer emulsion dispersion for maintaining is formed it into by mechanical shearing；（2）By the emulsion dispersion
It is polymerized, polymerization temperature is 50-80 DEG C, and the Vinyl Chloride Monomer emulsion droplet of the emulsifying forms mean diameter after polymerization
For 5.5-10.5 μm of latex；（3）The latex is removed into moisture removal through spray drying, then by bag hose by dry
Grain is collected rear wind delivers to pulverizer carries out micronizing, and the mean particle size after crushing is 3-5 μm, preferably 4 μm；More
Preferably, particle diameter distribution is in bimodal distribution, it was unexpectedly found that, when particle diameter distribution is bimodal distribution, molded thing
Surface viscosity is minimum and most stable in use.Latex after above-mentioned crushing is used as being shaped to used by eyelet pad and nose pad
Masterbatch.Molding can adopt injection mo(u)lding or molded.
The oil-soluble initiator can be the oil-soluble initiator known to skilled person.
In a preferred aspect of the present invention, the emulsifying agent is amphipathic emulsifying agent.It is highly preferred that the amphipathic breast
The structural formula of agent is as follows：
。
The preparation of the emulsifying agent refers to the synthetic method of general sulfonate emulsifier to carry out.
Research finds that the stability of dispersion liquid determines that can microdroplet suspension polymerisation be smoothed out, the size of dispersant liquid drop
There is substantial connection with the performance of the carrying out being polymerized and the polymer of acquisition, and the size of drop is closed due to close with emulsifying agent
System.When emulsifying agent hydrophilic is larger, it is impossible to enough that micelle is formed in water, when emulsifying agent hydrophilic is less, due to lipophilic group
Effect, micelle can not be formed.Based on this, the present inventor develops mentioned emulsifier first, and the emulsifying agent has optimal
HLB value, enabling guarantee that the polymer poly for stable micelle being formed in water and being obtained is right high and uniform, and be obtained in that
Mean diameter is 5.5-10.5 μm of preferable latex.
By release polymer degree of polymerization height and viscosity stabilization obtained in the method.
In the most preferred embodiment of the present invention, the surface of the eyelet pad and nose pad is via ozone process
Cross.
Ozone process can adopt the ozone of higher concentration carry out when finishing in eyelet pad and nose pad firm molding, so can be with
Avoid padding surface overdrying, so as to avoid padding surface checking.The present inventor it has been investigated that, the ozone of eyelet pad and nose pad
Process, ozone only has an effect in film surface, no significant ozone penetrates into that pad is internal, it is treated by ozone after glove
Outer surface is slided by viscous change, and inviscid, its tensile property is constant.Speculate that its mechanism is as follows：Ester group is formed by following reaction,
Due to the formation of ester group, increase the polarity of polymer surfaces, so that the polymer with favorable lubricating property can be preferably
Ground is bonded with eyelet pad and nose pad surface forming particulate matter.Its reaction mechanism is as follows：
Wherein X is chlorine.
In a preferred embodiment, the release polymer is blended with base when eyelet pad and nose pad is shaped to
In the starch or Pulvis Talci of release polymer weight meter 1-5 weight %.
The housing internal layer can be provided with heat-insulated inner bag.
The moxibustion post fixed station can be provided with fixed column, pallet, pallet guard bar.
The eyelet pad can be silicone rubber or sponge material.
The eyelet pad surrounding of the back side of shell may correspond to be each provided with Magnetotherapeutic apparatus at human body yang white cave and SIBAI point.
The left and right end of the back side of shell can be provided with adjustable fixing band.
The housing bottom is provided with the adjustable fixed support of activity.
Inventive shell employs integral structure, overcomes the defect that split type instrument high temperature deformation is present.Smoke evacuation post
One smoke evacuation cap is cased with outward, the exhaust smoke hole of adjustable size on cap of discharging fume can adjust smoke evacuation post by rotating smoke evacuation cap
Exhaust smoke hole, so as to adjust exhaust smoke level, reaches the purpose of regulation heating body burning velocity and efficacy strength.Back side of shell porous eyeglass
Coupling part and eyelet pad silastic material liner, make human body sensory comfortable, the inner correspondence human body yang white cave and four of housing
One Magnetotherapeutic apparatus is respectively set at white cave, and housing lower end is left two ash holes, is bolted with ash groove thereon, is provided with ash groove
Moxibustion post fixed station, instead of it is original in-convenience in use smoke evacuation cap on fixed pin, due to moxibustion post fixed rack structure simply, so
Folium Artemisiae Argyi moxibustion post or carbonization smokeless moxibustion post are applicable, and use and it is easy to clean, be difficult to stop working, ventilation condition is good, easy firing,
Working stability.
Naturopathy and bionics principle of the present invention using the Chinese traditional Chinese medical science.Moxibustion post burning when instrument works, in mirror body
The heat of generation directly improves ocular circulation through porous eyeglass, and by side Zanzhu near the eyes, Yuyao, te 23, hold
The stimulation that the acupuncture points such as tears, Jingming, Sibai are thirty minutes long, the physiology for adjusting each anatomical tissue structure nutrition of eye and metabolism are put down
Weighing apparatus, reaches to treating the effect treated and prevented by amblyopia and myopia.
In another aspect of this invention, a kind of ophtalmic treatments device external member is additionally provided, the external member includes that aforementioned ophthalmology is controlled
Treat device and moxibustion post.
In an especially preferred embodiment, it is heavy doped with moxibustion post gross weight 0.001-0.01 is accounted in the moxibustion post
The Pt-Pd/ZSM-12 catalyst of amount %, loaded catalyst of the catalyst for the molecular sieve carried Pt-Pd of ZSM-12, wherein Pt:
Pd=1:5-5:1（Mole）, the weight of active component Pt and Pd is 1.0-5.0 weight % of the loaded catalyst gross weight.Should
Catalyst is prepared using conventional infusion process.In normal conditions of use, the catalyst can make the CO contents reduction in moxibustion tobacco
More than 70%.The catalyst is preferably entrained in moxibustion post in powder form.
The present invention adopts moxibustion therapy, for acupuncture point around eyes and the effect of eyeball deep tissue, to eyeball without extruding, operation
It is easy, safe and reliable, without any side effects to human body；Therapeutic effect is good, takes effect first.General low myopia only needs 1 to 2 treatment
Journey (every course for the treatment of 30 days, once a day）, vision can recover normal；Control development is played to high myopia, while improving vision, preventing
The only purpose of retinal complication；To children's myopia using（Ametropic amblyopia, anisometropic amblyopia, strabismic amblyopia）And it is old
Year cataract（In early days）There is significant curative effect.
Description of the drawings
Fig. 1 is the structural representation of the present invention；
Fig. 2 is the internal structure schematic diagram of the present invention；
Fig. 3 is the structure schematic diagram of the present invention；
Fig. 4 is the ash groove and moxibustion post fixed rack structure schematic diagram of the present invention.
Specific embodiment
The present invention is further illustrated with reference to the accompanying drawings and examples：
Embodiment 1
Referring to accompanying drawing 1,2,3,4, the housing 10 of ophtalmic treatments device, including a spectacle, wherein, 10 front of housing is
Blind end, offers multiple convection holes 11 thereon, as shown in figure 3, being equiped with eyelet pad 21, eye on the opening at 10 back side of housing
The left and right position of circle pad 21 is respectively equiped with and the porous eyeglass 19 communicated inside housing 10, arranges between left and right porous eyeglass 19
There is nose pad 20, the upper end of housing 10 is provided with the left and right smoke evacuation post 12 being integrated with the injection of housing 10, left and right smoke evacuation post 12
Top surface offers exhaust smoke hole 13, is arranged with smoke evacuation cap 14 on left and right smoke evacuation post 12, and the top surface of cap 14 of discharging fume is provided with adjustable
Exhaust smoke hole 15, exhaust smoke hole 15 are provided with and can close blade and knob post 13, and 10 lower end of housing is provided with left and right ash hole 16, thereon spiral shell
Ash groove 17 is provided with, setting up in left and right ash groove 17 has the moxibustion post fixed station 30 for putting moxibustion post 40；10 internal layer of housing is arranged
There is heat-insulated inner bag 18；The moxibustion post fixed station 30 is provided with fixed column, pallet 32, pallet guard bar 31；The eyelet pad 21 be silicone rubber or
Sponge material；21 surrounding of eyelet pad at 10 back side of housing to be corresponded to and be each provided with Magnetotherapeutic apparatus at human body yang white cave and SIBAI point
22、23；The left and right end at 10 back side of housing is provided with adjustable fixing band 24；10 bottom of housing be provided with one it is movable
Adjustable fixed support.The eyelet pad and nose pad are molded using the polrvinyl chloride of microdroplet suspension process production.
Comparative example 1
Comparative example 1 differs only in eyelet pad and nose pad using commercially available polrvinyl chloride with embodiment 1（It is derived from neat
Shandong petro-chemical corporation）, the vinyl chloride produced by solution polymer method.
The eyelet pad and nose pad of embodiment 1 and ophtalmic treatments device obtained in comparative example 1 are carried out into tackiness test.
Under regular service conditionss, the eyelet pad and nose pad of embodiment 1 feel obvious tack-time for 18 months by user, and right
In ratio 1, by user, eyelet pad and nose pad feel that obvious tack-time is 6 months.Can substantially be seen by the above results
Go out, eyelet pad of the invention and nose pad have the significantly longer life-span, so that the life of whole device, significantly
Reduce cost.
This written description discloses the present invention using example, including optimal mode, and also enables those skilled in the art
Manufacture and using the present invention.The present invention can patentable scope be defined by the claims, and this area skill can be included
Other examples that art personnel expect.If this other examples have the structural elements of literal language not different from claims
Element, or if this other examples include equivalent structure element of the literal language without substantial differences with claims,
Then this other examples are intended within the scope of claims.In the case where inconsistent degree is not resulted in, by reference to
To be incorporated herein in place of all references of reference herein.
Claims (6)
1. a kind of ophtalmic treatments device, including the housing of periscopic, the housing front are blind end, are offered multiple on housing
Convection holes, are equiped with eyelet pad on the opening of back side of shell, the left and right position of eyelet pad is respectively equiped with and is communicated with enclosure interior
Porous eyeglass, be provided with nose pad between left and right porous eyeglass, the upper end of housing be provided be integrated with housing injection a left side,
Right smoke evacuation post, the top surface of left and right smoke evacuation post are provided with exhaust smoke hole one, are arranged with smoke evacuation cap, the top of cap of discharging fume on left and right smoke evacuation post
Face is provided with adjustable exhaust smoke hole two, and exhaust smoke hole two is provided with and can close blade and knob post, and the lower end of housing is provided with left and right ash discharge
Mouthful, ash hole is provided with to set up in ash groove, left and right ash groove the moxibustion post fixed station for putting moxibustion post, it is characterised in that：Institute
State eyelet pad and nose pad is made up of release polymer；
The eyelet pad and nose pad are molded using the polrvinyl chloride of microdroplet suspension process production；
The microdroplet suspension process is comprised the following steps：(1) by vinyl chloride, water, emulsifying agent and oil-soluble initiator in dispersion pump
In the presence of, the Vinyl Chloride Monomer emulsion dispersion for maintaining is formed it into by mechanical shearing；(2) emulsion dispersion is carried out
Polymerization, polymerization temperature are 50-80 DEG C, and the Vinyl Chloride Monomer emulsion droplet forms mean diameter after polymerization for 5.5-10.5
μm latex；(3) latex is removed into moisture removal through spray drying, then dry granule is collected by bag hose
Wind is delivered to pulverizer and carries out micronizing afterwards, and the mean particle size after crushing is 3-5 μm, and particle diameter distribution is in bimodal distribution；On
The latex after crushing is stated as the masterbatch for being shaped to eyelet pad and used by nose pad；
The emulsifying agent is amphipathic emulsifying agent, and the structural formula of the amphipathic emulsifying agent is as follows：
2. ophtalmic treatments device according to claim 1, it is characterised in that：The housing internal layer is provided with heat-insulated inner bag.
3. ophtalmic treatments device according to claim 1, it is characterised in that：The moxibustion post fixed station is provided with fixed column, support
Disk, pallet guard bar.
4. ophtalmic treatments device according to claim 1, it is characterised in that：The eyelet pad surrounding correspondence of the back side of shell
Magnetotherapeutic apparatus are each provided with human body yang white cave and SIBAI point.
5. ophtalmic treatments device according to claim 2, it is characterised in that：The left and right end of the back side of shell is provided with
Adjustable fixing band.
6. a kind of ophtalmic treatments device external member, the external member include being filled according to ophtalmic treatments in any one of the preceding claims wherein
Put and moxibustion post.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510330977.4A CN104856799B (en) | 2015-06-16 | 2015-06-16 | Ophtalmic treatments device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510330977.4A CN104856799B (en) | 2015-06-16 | 2015-06-16 | Ophtalmic treatments device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104856799A CN104856799A (en) | 2015-08-26 |
| CN104856799B true CN104856799B (en) | 2017-04-05 |
Family
ID=53903284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510330977.4A Active CN104856799B (en) | 2015-06-16 | 2015-06-16 | Ophtalmic treatments device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104856799B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105498016B (en) * | 2016-01-13 | 2019-01-01 | 青岛市妇女儿童医院 | A kind of lacrimal passage cleaning water collector |
| CN108042345A (en) * | 2017-12-26 | 2018-05-18 | 武汉浩宏科技有限公司 | Vibration massage therapy instrument is fumigated in a kind of ophthalmology water-bath |
| CN108113877A (en) * | 2017-12-29 | 2018-06-05 | 武汉佰美斯医疗科技有限公司 | A kind of cooling ophthalmology physiotherapy equipment |
| CN108670814A (en) * | 2018-06-01 | 2018-10-19 | 曹利成 | A kind of eye moxibustion massage instrument and its Chinese medicine walnut shell medicament used |
| CN109330843B (en) * | 2018-11-26 | 2020-11-27 | 连云港市一明医疗科技有限公司 | Device for preventing and treating myopia |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201019908Y (en) * | 2007-03-26 | 2008-02-13 | 汪琰琪 | Ophthalmology treating instrument |
| CN201131847Y (en) * | 2007-12-27 | 2008-10-15 | 申晓丽 | Magneto-moxibustion integration hypometropia and amblyopia therapeutic equipment |
| CN202154855U (en) * | 2011-01-25 | 2012-03-07 | 黄春源 | Comprehensive traditional Chinese medicine therapeutic apparatus for myopia and amblyopia |
| CN102952224A (en) * | 2011-08-26 | 2013-03-06 | 沈阳化工股份有限公司 | Low-polymerization-degree polyvinyl chloride pasty resin preparation method |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006102406A (en) * | 2004-10-01 | 2006-04-20 | Kimio Mizukoshi | Myopia preventing and visual acuity restoring device |
| JP2010063542A (en) * | 2008-09-09 | 2010-03-25 | Masaki Ariga | Instrument for curing visual fatigue |
-
2015
- 2015-06-16 CN CN201510330977.4A patent/CN104856799B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201019908Y (en) * | 2007-03-26 | 2008-02-13 | 汪琰琪 | Ophthalmology treating instrument |
| CN201131847Y (en) * | 2007-12-27 | 2008-10-15 | 申晓丽 | Magneto-moxibustion integration hypometropia and amblyopia therapeutic equipment |
| CN202154855U (en) * | 2011-01-25 | 2012-03-07 | 黄春源 | Comprehensive traditional Chinese medicine therapeutic apparatus for myopia and amblyopia |
| CN102952224A (en) * | 2011-08-26 | 2013-03-06 | 沈阳化工股份有限公司 | Low-polymerization-degree polyvinyl chloride pasty resin preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104856799A (en) | 2015-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104856799B (en) | Ophtalmic treatments device | |
| CN201182680Y (en) | Chinese medicine steam eye protector | |
| CN110381900A (en) | Therapeutic ultrasound for eye disorders | |
| CN205322757U (en) | Multifunctional fumigator | |
| CN205094967U (en) | Multiple mode therapeutic instrument of ophthalmology | |
| CN107320240A (en) | A kind of adaptive eye physical therapy device | |
| CN106176188A (en) | A kind of multi-functional Chinese medicine fumigates therapeutic instrument | |
| CN206214268U (en) | A kind of eye health wet fog therapeutic equipment | |
| CN106491353A (en) | A kind of comprehensive modern Chinese medicine physical therapy moxa-moxibustion instrument | |
| WO2010003327A1 (en) | Vision-improving instrument for curing ophthalmological visual obstruction disease | |
| CN205459822U (en) | Massage therapy appearance is fumigated to portable dry eyes | |
| CN104997626A (en) | Novel intelligent moxibustion physiotherapy eye care instrument | |
| CN2684798Y (en) | Multifunction myopia and brain health care treating instrument | |
| CN201019908Y (en) | Ophthalmology treating instrument | |
| CN107678184A (en) | Anion medical science glasses | |
| CN201049016Y (en) | Therapeutic instrument for ophthalmology | |
| CN205322753U (en) | To human mouth, nose or stifling stifling appearance of eye | |
| CN206044818U (en) | A kind of pair of mist regards Vacuum Pressure Swing instrument for eye disease | |
| CN210811963U (en) | Traditional Chinese medicine fumigation hot compress massage xerophthalmia therapeutic instrument | |
| CN108309779A (en) | A kind of health Spraying type therapeutic device tool | |
| RU112623U1 (en) | OPHTHALMIC COMPLEX | |
| CN211356704U (en) | Rheumatism immune arthropathy rehabilitation physiotherapy device | |
| CN208065337U (en) | It is a kind of to integrate the smoked Physiotherapeutic eyeshade with hot compress of mist | |
| CN2218547Y (en) | Quick effect sight enhancing instrument | |
| CN205569165U (en) | Scalpel for ophthalmic medical care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic therapy device Effective date of registration: 20190222 Granted publication date: 20170405 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY CO.,LTD. Registration number: 2019320000102 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200416 Granted publication date: 20170405 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: 2019320000102 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic therapy device Effective date of registration: 20200420 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980001626 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210819 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980001626 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic treatment device Effective date of registration: 20210820 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2021980008026 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221017 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY CO.,LTD. Registration number: Y2021980008026 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic treatment device Effective date of registration: 20221018 Granted publication date: 20170405 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY CO.,LTD. Registration number: Y2022980018663 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |